Carlos Cuesta‐Mateos

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Emma Andersson, S. Pützer, Bhagwan Yadav et al. · Leukemia · 2017 · 97 citations

Medicine, Molecular Biology, Oncology +15

The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model

Marina García-Peydró, Patricia Fuentes, Marta Mosquera et al. · Journal of Clinical Investigation · 2018 · 66 citations · Full text

Medicine, Hematology, Oncology +13

Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner

Anna Kreutzman, Beatriz Colom-Fernández, Ana Marcos‐Jiménez et al. · Clinical Cancer Research · 2017 · 44 citations

Medicine, Oncology, Pharmacology +17

Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia

Carlos Cuesta‐Mateos, Sonia López-Giral, Manuel Alfonso-Pérez et al. · Experimental Hematology · 2010 · 41 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +16

Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma

Beatriz Somovilla-Crespo, Manuel Alfonso-Pérez, Carlos Cuesta‐Mateos et al. · Journal of Hematology & Oncology · 2013 · 40 citations · Full text

Medicine, Immunology, Oncology +14